Drug reduces inflammation in stroke patients

March 26th, 2018 | Posted by admin in Uncategorized

An anti-inflammatory drug given to patients in the early stages of a stroke has been shown by researchers to reduce harmful inflammation. The drug, Kineret©, licensed for treating rheumatoid arthritis, was given as a small injection just under the skin without giving the patients any identifiable adverse reactions.
Source: Care Giving Science Daily

You can follow any responses to this entry through the RSS 2.0 You can leave a response, or trackback.

Leave a Reply

Your email address will not be published. Required fields are marked *